Table 2 Univariable analysis of clinical and CMR characteristics for prediction of adverse events
MACE | Cardiovascular mortality | |||
|---|---|---|---|---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | |
Age | 1.02 (1.01–1.03) | 0.002 | 1.03 (1.02–1.05) | < 0.001 |
Male | 1.68 (1.27–2.21) | < 0.001 | 1.60 (1.16–2.20) | 0.004 |
Body mass index | 0.98 (0.95–1.02) | 0.311 | 1.01 (0.95–1.03) | 0.485 |
Hypertension | 0.83 (0.62–1.10) | 0.190 | 0.88 (0.63–1.22) | 0.431 |
Diabetes mellitus | 0.86 (0.64–1.15) | 0.307 | 0.87 (0.62–1.23) | 0.429 |
Dyslipidemia | 1.00 (0.76–1.32) | 0.978 | 1.00 (0.73–1.38) | 0.978 |
Current or previous smoking | 0.96 (0.68–1.35) | 0.811 | 0.81 (0.53–1.22) | 0.309 |
Family history of coronary artery disease | 0.72 (0.51–1.02) | 0.064 | 0.61 (0.40–0.94) | 0.023 |
Stroke | 0.77 (0.37–1.83) | 0.371 | 0.74 (0.30–1.19) | 0.466 |
Renal failure | 1.36 (0.44–4.26) | 0.595 | 1.27 (0.31–5.12) | 0.738 |
Peripheral atheroma | 1.12 (0.29–3.37) | 0.566 | 1.54 (0.34–4.45) | 0.319 |
Prior hospitalization for heart failure | 1.57 (0.74–3.34) | 0.240 | 1.87 (0.83–4.24) | 0.133 |
Presence of ischemia | 4.64 (3.49–6.17) | < 0.001 | 4.00 (2.85–5.61) | < 0.001 |
Number of segments of ischemia | 1.60 (1.51–1.70) | < 0.001 | 1.51 (1.40–1.62) | < 0.001 |
Presence of unrecognized MI | 2.88 (2.08–3.99) | < 0.001 | 2.77 (1.89–4.06) | < 0.001 |
Number of segments of LGE | 1.52 (1.41–1.63) | < 0.001 | 1.49 (1.37–1.62) | < 0.001 |
LV ejection fraction, per 10% | 0.88 (0.79–0.97) | 0.014 | 0.93 (0.82–1.05) | 0.245 |
LV end-diastolic volume index, per 10 ml/m2 | 1.06 (1.01–1.11) | 0.025 | 1.03 (0.97–1.09) | 0.348 |
LV end-systolic volume index, per 10 ml/m2 | 1.06 (1.02–1.13) | 0.009 | 1.04 (0.97–1.11) | 0.252 |
RV ejection fraction, % | 0.96 (0.79–1.19) | 0.411 | 1.06 (0.78–1.53) | 0.681 |